Literature DB >> 4207045

Seizures induced by allylglycine, 3-mercaptopropionic acid and 4-deoxypyridoxine in mice and photosensitive baboons, and different modes of inhibition of cerebral glutamic acid decarboxylase.

R W Horton, B S Meldrum.   

Abstract

1. DL-C-Allyglycine, 4-deoxypyridoxine hydrochloride and 3-mercaptopropionic acid have been studied with reference to their convulsant effects in mice and in baboons (Papio papio) with photosensitive epilepsy, and their action on the cerebral enzyme synthesizing gamma-aminobutyric acid (L-glutamate-1-carboxy-lyase).2. In mice, the ED(50) values for seizures following intraperitoneal injection were allylglycine 1.0 mmol/kg body weight, 4-deoxypyridoxine 1.1 mmol/kg and 3-mercaptopropionic acid 0.27 mmol/kg. Latency to seizure onset was longest after allylglycine (44-240 min), intermediate after 4-deoxypyridoxine (9-114 min) and shortest after 3-mercaptopropionic acid (2.5-8 min).3. In Papio papio intravenous administration of subconvulsant doses of allylglycine (0.87-3.1 mmol/kg), or of 4-deoxypyridoxine (0.21-0.53 mmol/kg) enhanced the occurrence and persistence of myoclonic responses to intermittent photic stimulation, and augmented the associated electroencephalographic abnormalities, without modifying their character or distribution. Higher doses produced brief seizures recurring at regular intervals, between 2-14 h after allylglycine (4.0-4.3 mmol/kg) or 1-4 h after 4-deoxypyridoxine (0.53-0.87 mmol/kg). Electroencephalographically these seizures originated unilaterally in the occipital or posterior parietal cortex.4. In Papio papio photically-induced epileptic responses were enhanced 5-10 min after the intravenous injection of 3-mercaptopropionic acid (0.09-0.28 mmol/kg). A sequence of brief generalized seizures followed by complete recovery occurred 4-17 min after the injection of 3-mercaptopropionic acid (0.28-0.38 mmol/kg). Fatal status epilepticus followed the injection of 3-mercaptopropionic acid (0.57-0.75 mmol/kg). E.E.G. records showed generalized cortical involvement at the onset of the seizures.5. L-Glutamate 1-carboxy-lyase (GAD) activity was determined in whole brain homogenates from mice killed at various intervals after receiving i.p. a convulsant dose of one of the compounds. Inhibition of GAD activity was evident 30-60 min before seizure onset following allylglycine or 4-deoxypyridoxine administration, and was maximal (40-60%) just before or during seizure activity. Addition of pyridoxal phosphate to the brain homogenate relieved inhibition produced by 4-deoxypyridoxine but not that produced by allylglycine. Inhibition of GAD activity in brain homogenates from animals killed 2 or 4 min after injection of a convulsant dose of 3-mercaptopropionic acid varied from 0-49% depending on the dose of 3-mercaptopropionic acid and the concentration of substrate in the assay system.6. Kinetic analysis of the inhibition of GAD activity following direct addition of the compounds to mouse brain homogenates indicated that 3-mercaptopropionic acid (0.01-0.5 mM) was competitive with respect to the substrate. A comparable percentage inhibition of GAD activity was obtained only with much higher concentrations of 4-deoxypyridoxne, i.e. 10-50 mM. Allylglycine in vitro was a very weak inhibitor of GAD activity.7. Three biochemically different mechanisms underlie the inhibition of cerebral GAD activity that precedes seizures induced by ailylglycine, 4-deoxypyridoxine and 3-mercaptopropionic acid. The data are consistent with a critical reduction in the rate of synthesis of gamma-aminobutyric acid being responsible for the onset of seizures.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4207045      PMCID: PMC1776427          DOI: 10.1111/j.1476-5381.1973.tb08267.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

1.  Some properties of L-glutamic decarboxylase in mouse brain.

Authors:  E ROBERTS; D G SIMONSEN
Journal:  Biochem Pharmacol       Date:  1963-02       Impact factor: 5.858

2.  Convulsant hydrazides. II. Comparison of electrical changes and enzyme inhibition induced by the administration of thiosemicarbazide.

Authors:  K F KILLAM
Journal:  J Pharmacol Exp Ther       Date:  1957-02       Impact factor: 4.030

3.  Convulsant hydrazides. I. In vitro and in vivo inhibition of vitamin B6 enzymes by convulsant hydrazides.

Authors:  K F KILLAM; J A BAIN
Journal:  J Pharmacol Exp Ther       Date:  1957-02       Impact factor: 4.030

4.  Antagonism between bicuculline and GABA in the cat brain.

Authors:  D R Curtis; A W Duggan; D Felix; G A Johnston; H McLennan
Journal:  Brain Res       Date:  1971-10-08       Impact factor: 3.252

5.  Inhibition of protein synthesis in brain subcellular fractions by the convulsant allylglycine.

Authors:  M A De Canal; G R De Lores Arnaiz
Journal:  Biochem Pharmacol       Date:  1972-01       Impact factor: 5.858

6.  Bicuculline and inhibition in the thalamus.

Authors:  A W Duggan; H McLennan
Journal:  Brain Res       Date:  1971-01-08       Impact factor: 3.252

7.  Effects of various substituted hydrazones and hydrazines of pyridoxal-5'-phosphate on brain glutamate decarboxylase.

Authors:  R Tapia; J Awapara
Journal:  Biochem Pharmacol       Date:  1969-01       Impact factor: 5.858

8.  Correlative changes of pyridoxal kinase pyridoxal-5'-phosphate and glutamate decarboxylase in brain, during drug-induced convulsions.

Authors:  R Tapia; M Pérez de la Mora; G H Massieu
Journal:  Ann N Y Acad Sci       Date:  1969-09-30       Impact factor: 5.691

9.  The comparative effects of various hydrazides on -aminobutyric acid and its metabolism.

Authors:  J D Wood; D E Abrahams
Journal:  J Neurochem       Date:  1971-06       Impact factor: 5.372

10.  Pharmacology of cortical inhibition.

Authors:  K Krnjević; M Randić; D W Straughan
Journal:  J Physiol       Date:  1966-05       Impact factor: 5.182

View more
  21 in total

1.  A comparison of the effects of allylglycine and 2-keto-4-pentenoic acid on cerebral glutamic acid decarboxylase activity and convulsions in mice [proceedings].

Authors:  R W Horton; B S Meldrum
Journal:  Br J Pharmacol       Date:  1977-11       Impact factor: 8.739

2.  Cofactor interactions and the regulation of glutamate decarboxylase activity.

Authors:  D L Martin; S B Martin; S J Wu; N Espina
Journal:  Neurochem Res       Date:  1991-03       Impact factor: 3.996

3.  In vivo benzodiazepine receptor occupancy by CL 218,872 visualized by positron emission tomography in the brain of the living baboon: modulation by GABAergic transmission and relation with anticonvulsant activity.

Authors:  V de la Sayette; C Chavoix; E Brouillet; P Hantraye; M Kunimoto; M Khalili-Varasteh; B Guibert; C Prenant; M Mazière
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

4.  Folic acid and the inhibition of brain L-glutamic decarboxylase.

Authors:  G Tunnicliff; T T Ngo
Journal:  Experientia       Date:  1977-01-15

5.  Evidence for the involvement of a GABA-mediated inhibition in the hypovolaemia-induced vasopressin release.

Authors:  W Knepel; D Nutto; G Hertting
Journal:  Pflugers Arch       Date:  1980-11       Impact factor: 3.657

Review 6.  Pharmacology of GABA-mediated inhibition of spinal cord neurons in vivo and in primary dissociated cell culture.

Authors:  R L Macdonald; A B Young
Journal:  Mol Cell Biochem       Date:  1981-08-11       Impact factor: 3.396

7.  Degenerative hippocampal pathology in mice infected with scrapie.

Authors:  J R Scott; H Fraser
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

8.  Microperfusion of 3-MPA into the brain augments GABA.

Authors:  Andrew P Mayer; Ivan Osorio; Craig E Lunte
Journal:  Epilepsy Behav       Date:  2013-10-02       Impact factor: 2.937

9.  The relationship between the anticonvulsant properties of SC-13504 and its plasma levels, measured by polarography, in baboons with photosensitive epilepsy.

Authors:  B S Meldrum; M R Smyth; W Franklin-Smyth; J M Clifford
Journal:  Psychopharmacology (Berl)       Date:  1976-12-21       Impact factor: 4.530

10.  Interaction of uridine with GABA binding sites in cerebellar membranes of the rat.

Authors:  P Guarneri; R Guarneri; C Mocciaro; F Piccoli
Journal:  Neurochem Res       Date:  1983-12       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.